...
首页> 外文期刊>BMC Infectious Diseases >Molecular epidemiology study of Mycobacterium tuberculosis and its susceptibility to anti-tuberculosis drugs in Indonesia
【24h】

Molecular epidemiology study of Mycobacterium tuberculosis and its susceptibility to anti-tuberculosis drugs in Indonesia

机译:印度尼西亚结核分枝杆菌的分子流行病学研究及其对抗结核药物的敏感性

获取原文

摘要

Genotyping of Mycobacterium tuberculosis helps to understand the molecular epidemiology of tuberculosis and to address evolutionary questions about the disease spread. Certain genotypes also have implications for the spread of infection and treatment. Indonesia is a very diverse country with a population with multiple ethnicities and cultures and a history of many trade and tourism routes. This study describes the first attempt to map the molecular epidemiology of TB in the Indonesian archipelago. From 2008 to 2011, 404 clinical specimens from sputum-smear (SS+) TB patients, age ≥15?years, were collected from 16?TB referral primary health centers (PHC) in 16 provincial capitals in Indonesia. Susceptibility testing to first line drugs was conducted for 262 samples using the agar proportion method as per WHO guidelines. Spoligotyping was done on all samples. Ninety-three of the 404 samples (23?%) were from the Beijing family, making it the predominant family in the country. However, the geographic distribution of the family varied by region with 86/294 (29.3?%) in the western region, 6/72 (8.3?%) in the central region, and 2/72 (2.8?%) in the eastern region (p?
机译:结核分枝杆菌的基因分型有助于了解结核的分子流行病学,并解决有关疾病传播的进化问题。某些基因型也对感染和治疗的传播有影响。印度尼西亚是一个非常多元化的国家,其人口具有多种种族和文化,并且具有许多贸易和旅游路线的历史。这项研究描述了印尼群岛首次尝试绘制结核病分子流行病学图。从2008年至2011年,从印度尼西亚16个省会城市的16个TB推荐初级卫生保健中心(PHC)收集了404岁以上年龄≥15岁的痰涂片(SS +)TB患者的临床标本。根据WHO指南,使用琼脂比例法对262个样品进行了一线药物敏感性试验。所有样本均进行了盲法分型。 404个样本中有93个(占23%)来自北京家庭,使其成为该国的主要家庭。但是,该家庭的地理分布因地区而异,西部地区为86/294(29.3%),中部地区为6/72(8.3%),东部地区为2/72(2.8%)。区域(p≤0.001)。中部和东部地区的主要基因型来自东非印度人(EAI)家族,分别占分离株的15.3%(11/72)和26.3%(10/38)。在262株分离物中测试了对一线抗结核药物的药物敏感性。 162(61.8%)菌株对所有结核病药物均易感,70(26.7%)对单药耐药,16(6.1%)对多药耐药,14(5.4%)对多药耐药(MDR) 。在易感,单药耐药,多药耐药和耐多药组中,北京家族分离株的比例为33/162(20.4%),28/70(40.0%),6/16(37.5%)和分别为3/14(21.4%)。总体而言,北京家族分离株对任何一线结核病药物的耐药性均显着高于非北京家族[37/71(52.1%)vs. 63/191(33.0%)(p-value?=? 0.003)]。印度尼西亚结核分枝杆菌基因型的分布显示出很高的遗传多样性,并且倾向于随地理区域而变化。药物敏感性测试证实,印度尼西亚的北京结核分枝杆菌家族比其他家族对一线抗结核药物表现出更大的抵抗力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号